Industry News
Gene therapy hopes for X-linked lymphoproliferative disease
Researchers have uncovered why some individuals with X-linked lymphoproliferative live far longer than expected, which could lead to a gene therapy for the disease. [ + ]
Gene therapy hopes for X-linked lymphoproliferative
Researchers have uncovered why some individuals with X-linked lymphoproliferative live far longer than expected, which could lead to a gene therapy for the disease. [ + ]
vivoPharm buys RMIT's toxicology business
RMIT will sell its toxicology testing unit, RDDT, to vivoPharm Technologies in exchange for a 20% stake in the contract research organisation (CRO). [ + ]
CO2 is messing with coral skeletons
An international scientific team has carried out the world’s first analysis of the impact of ocean acidification on every gene in the coral genome, throwing new light on the likely fate of corals under climate change. [ + ]
Genes identified for common childhood obesity
An international collaborative study including researchers from The University of Western Australia (UWA) has identified at least two new gene variants that increase the risk of common childhood obesity. [ + ]
SA Government, via BioSA, funds $1 million IP initiative
The Government of South Australia has announced it will fund a new $1 million initiative over three years to help South Australia’s three main universities seek patent protection for their intellectual property (IP). [ + ]
Government’s $10 million investment in science advice
The capacity of the Prime Minister’s Science, Engineering and Innovation Council (PMSEIC) has been reinforced by a $10 million government commitment to the Council’s new arrangements. [ + ]
Fatty acids fight cancer spread
Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumours, preventing the advance to secondary stage cancers, according to pharmacy researchers at the University of Sydney. [ + ]
QRxPharma completes trials of MoxDuo CR
QRxPharma (ASX:QRX) has completed two phase 1 trials of its MoxDuo CR dual-opioid tablets, and revealed some positive pharmacokinetic results. [ + ]
Sirtex Medical Q3 dose sales grow 34%
NSW-based biotech Sirtex Medical (ASX:SRX) said Q3 dose sales of its SIR-Spheres microspheres liver cancer treatment a record grew 34% year-on-year. [ + ]
Brain tumour surgery aid gets orphan drug status
Gliolan, a drug licensed to Melbourne's STA which has the ability to make brain tumours glow red during neurosurgery, has been granted orphan drug status by the TGA. [ + ]
Plant expert to develop tests for pests in Japan
A Murdoch University PhD candidate has won a $4500 scholarship to develop diagnostic tests for a pine tree pest. [ + ]
Changing climate can affect fish fertility
Warmer water temperatures can greatly increase the reproductive capacity of the widely distributed pest fish species Gambusia, or mosquito fish, a new study has found. [ + ]
New institute to lead climate change research
Last week's opening of the Hawkesbury Institute for the Environment at the University of Western Sydney provides Australia with a world-class research institute to tackle the impacts of climate change. [ + ]
Alchemia partner applies to sell fondaparinux in EU
Dr Reddy's Laboratories has submitted an EU marketing authorisation application covering partner Alchemia's (ASX:ACL) fondaparinux anticoagulant. [ + ]